stockmarketproxy
/
BBIONasdaq SEC EDGAR

BridgeBio Pharma, Inc.

Pharmaceutical Preparations·PALO ALTO, CA·FY end 12/31·CIK 1743881
OverviewFinancialsCompensationGovernanceInsidersFilings

Board of Directors

12 members · 10 independent · FY 2025
DirectorRoleTenureAgeCommitteesIndep.Annual fees
Randal W. ScottDirectorAudit
Eric Aguiar, M.D.Director6yAudit
Jennifer E. CookDirector6yComp
Andrea J. EllisDirector4yAudit
Fred HassanLead Independent Director4yComp
Ali J. SatvatDirector9yCompNCG
Neil Kumar, Ph.D.CEO and Director10y
Charles Homcy, M.D.Lead Director7y
Douglas A. DachilleDirector4yAuditNCG
Ronald J. DanielsDirector6yComp
Andrew W. Lo, Ph.D.Director5yNCG
Heidi ValantineDirectorNCG

Risk-factor diff

10-K Item 1A — YoY changes

Need at least two years of 10-K filings to compute. Will populate once both this year's and last year's 10-Ks have been ingested.

Policies & disclosures

Clawback, anti-hedging, stock ownership, and related-party policies will populate from extracted proxy sections.